When.com Web Search

  1. Ad

    related to: who treats splenomegaly in adults treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Ropeginterferon alfa-2b - Wikipedia

    en.wikipedia.org/wiki/Ropeginterferon_alfa-2b

    In the European Union, ropeginterferon alfa-2b is indicated as monotherapy in adults for the treatment of polycythemia vera without symptomatic splenomegaly. [4] In the United States it is indicated for the treatment of polycythemia vera. [2] [3] [6] Ropeginterferon alfa-2b showed promising clinical activities in the treatment of moderate COVID ...

  3. Fedratinib - Wikipedia

    en.wikipedia.org/wiki/Fedratinib

    Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. [5] It is used in the form of fedratinib hydrochloride capsules that are taken by mouth. It is a semi-selective inhibitor of Janus kinase 2 (JAK-2). [5] [6] It was approved by the FDA on 16 August 2019. [5]

  4. Splenomegaly - Wikipedia

    en.wikipedia.org/wiki/Splenomegaly

    Splenomegaly is an enlargement of the spleen. [1] The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen.Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or platelets in any combination; a compensatory proliferative response in the bone marrow; and the ...

  5. Felty's syndrome - Wikipedia

    en.wikipedia.org/wiki/Felty's_syndrome

    There is no real treatment for Felty's syndrome, rather the best method in management of the disease is to control the underlying rheumatoid arthritis. Immunosuppressive therapy for RA often improves granulocytopenia and splenomegaly; this finding reflects the fact that Felty's syndrome is an immune-mediated disease.

  6. Momelotinib - Wikipedia

    en.wikipedia.org/wiki/Momelotinib

    In November 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Omjjara, intended for the treatment of disease-related splenomegaly or symptoms in adults with moderate-to-severe anemia who have primary myelofibrosis, post-polycythaemia ...

  7. Organomegaly - Wikipedia

    en.wikipedia.org/wiki/Organomegaly

    Splenomegaly: Medical imaging: Largest dimension of over 11 cm, [27] [28] or craniocaudal height of 13 [29] cm. Moderate splenomegaly: the largest dimension is between 11–20 cm [27] Severe splenomegaly: the largest dimension is greater than 20 cm [27] Autopsy: Weight over upper limit of standard reference range, of 230 g (8.1 oz) [12] [13 ...

  8. Meet the 24-year-old helping Lilly test a preventive ...

    www.aol.com/finance/meet-24-old-helping-lilly...

    The international Primary Prevention Trial will enroll roughly 250 young adults at high risk of developing early-onset Alzheimer’s, which may appear in a person’s thirties, forties, or fifties.

  9. Autoimmune lymphoproliferative syndrome - Wikipedia

    en.wikipedia.org/wiki/Autoimmune_lymphoprolife...

    Autoimmune disease is the second most common clinical manifestation and one that most often requires treatment. The most common autoimmune presentations include autoimmune cytopenias, which can be mild to very severe and intermittent or chronic. [5] These include autoimmune hemolytic anemia, autoimmune neutropenia, and autoimmune thrombocytopenia.